V y v a n s e : N o w

3

m i l l i o n p r e s c r i p t i o n s f i l l e d f o r A D H D .

»

>

Consistent Carl

throughout the day,

even after school.

W hen C arl's A D H D sym p to m s are

co ntro lled, even at

6

pm, he's a b le to fo cus and

pay attention so friends can see the child I see.

Vyvanse has been shown to provide significant

symptom control for up to 12 hours from

morning through homework and family time.

If yo u r child w ith A D H D has tro ub le fo cusing,

a sk the doctor abo ut V yva n se .

1 -8 6 6 -6 3 0 -12 8 3 , w w w .vyvanse.com

CONSISTENTLY VYVANSE

IMPORTANT SAFETY INFORMATION

Vyvanse is indicated for the treatment of ADHD. Efficacy based on two

controlled trials in children aged 6 to 12 and one controlled trial in adults.

Tell the doctor about any heart conditions, including structural

abnorm alities, that you, your child, or a fam ily m em ber, m ay have.

Inform the doctor/m m ed/afe/y if you or your child develops symptoms

that suggest heart problems, such as chest pain or fainting.

Vyvanse should not be taken if you or your child has advanced disease

of the blood vessels (arteriosclerosis); symptomatic heart disease;

moderate to severe high blood pressure; overactive thyroid gland

(hyperthyroidism); known allergy or unusual reactions to drugs called

sympathomimetic amines (for example, pseudoephedrine); seizures;

glaucoma; a history of problems with alcohol or drugs; agitated states;

taken a monoamine oxidase inhibitor (MAOI) within the last 14 days.

Tell the doctor

before

taking Vyvanse if you or your child is being

treated for or has symptoms of depression (sadness, worthlessness, or

hopelessness) or bipolar disorder; has abnormal thought or visions, hears

abnormal sounds, or has been diagnosed with psychosis; has had seizures

or abnormal EEGs; has or has had high blood pressure; exhibits aggressive

behavior or hostility. Tell the doctor

im m ediately

if you or your child

develops any of these conditions or symptoms while taking Vyvanse.

Abuse of am phetam ines m ay lead to dependence. M isuse of

am phetam ine m ay cause sudden death and serious cardiovascular

adverse events. These events have also been reported rarely with

am phetam ine use.

Vyvanse was generally well tolerated in clinical studies. The most

common side effects reported in studies of Vyvanse were:

children -

decreased appetite,difficulty falling asleep, stomachache,and irritability;

a d u lt-

decreased appetite,difficulty falling asleep,and dry mouth.

Aggression, new abnorm al thoughts/behaviors, m ania, growth

suppression,worsening of motion or verbal tics,and Tourette's syndrome

have been associated with use of drugs of this type. Tell the doctor if

you or your child has blurred vision while taking Vyvanse.

Please see Patient Brief Sum m ary of Full Prescribing Inform ation

on the follow ing page.

(■ 'ShirS

...your ADHD Support Company™

62009

Sh

ire US

lnc.VYV

-00163

01/09

You are encouraged to report negative side effects of prescription drugs to the FDA. V isit www.fda.gov/m edwatch, or call 1-80 0 -FD A -10 88.